Table 3 ANC and IPTp coverage at baseline and endline as documented on the ANC card, by study arm
| Â | Baseline | Endline | Difference in differencesa | p-value for DiD | ||
|---|---|---|---|---|---|---|
Control | Intervention | Control | Intervention | |||
N = 188 | N = 186 | N = 180 | N = 180 | |||
Number of IPTp doses (mean, 95% CI) | 2.3 (1.9, 2.8) | 2.3 (1.8, 2.9) | 2.1 (1.53, 2.9) | 2.9 (2.3, 3.8) | 0.9 (− 0.3, 2.1) | 0.15 |
IPTp1+ (%, 95% CI) | 86.2 (73.5, 93.4) | 80.7 (65.4, 90.2) | 75.6 (54.6, 88.8) | 86.1 (74.9, 92.8) | 16.1%-points (− 8.5, 40.7) | 0.20 |
IPTp2+ (%, 95% CI) | 73.4 (55.2, 86.1) | 69.9 (57.1, 80.2) | 64.4 (41.3, 82.3) | 72.2 (50.3, 87.0) | 11.3%-points (− 27.6, 50.1) | 0.57 |
IPTp3+ (%, 95% CI) | 54.3 (39.3, 68.5) | 50.5 (35.0, 66.0) | 47.2 (28.6, 66.7) | 61.1 (40.6, 78.4) | 17.6%-points (− 16.3, 51.5) | 0.31 |
IPTp4+ (%, 95% CI) | 16.0 (8.4, 28.3) | 21.5 (8.3, 45.3) | 21.1 (12, 34.5) | 46.7 (29.6, 64.6) | 20.0%-points (− 7.2, 47.3) | 0.15 |
IPTp5+ (%, 95% CI) | 2.7 (1.0, 6.8) | 4.3 (1.1, 15.4) | 2.2 (0.6, 8.1) | 27.8 (17.3, 41.4) | 23.9%-points (9.4, 38.4) | 0.001 |
Number of ANC visits (mean, 95% CI) | 3.2 (2.9, 3.6) | 3.23 (2.9, 3.6) | 3.4 (3.0, 3.7) | 3.6 (3.6, 3.7) | 0.2 (− 0.3, 0.8) | 0.43 |
ANC1+ (%, 95% CI) | 89.4 (80.4, 94.5) | 90.3 (76.8, 96.4) | 94.4 (84.7, 98.1) | 97.8 (94.6, 99.1) | 2.4%-points (− 10.7, 15.5) | 0.72 |
ANC4+ (%, 95% CI) | 62.2 (49.4, 73.5) | 61.8 (50.5, 72.0) | 65.0 (48.5, 78.6) | 77.2 (73.1, 80.9) | 12.6%-points (− 7.0, 3.22) | 0.21 |